WHO Looks In The Direction Of Madagascar’s COVID Organics, Thinks Clinical Observation

Facebook
Twitter
LinkedIn
WhatsApp

The World Health Organisation (WHO) is considering Madagascar’s COVID Organics for clinical observation process.

The President of Madagascar, Andry Rajoelina made this known on Wednesday, saying that he and the Director-General of WHO, Tedros Ghebreyesus, had a successful interaction on COVID Organics.

In a tweet, President Rajoelina said, “Successful exchange with Dr Tedros who commends Madagascar’s efforts in the fight against COVID-19 and congratulates us for the discovery of COVID Organics.

Madagascar’s COVID Organics

Fight For Release: Court Fixes June 2 To Hear Motion Filed By Kalu

“WHO will sign a confidentiality clause on its formulation and will support the clinical observations process in Africa.

“Following WHO’s invitation to be part of « Solidarity Trial » for clinical trials, Madagascar will prove the effectiveness of its third protocol that combines two injectable medicines that are different from COVID Organics.”

COVID Organics has been touted to be an effective medicine for the treatment of the novel coronavirus.

Facebook
Twitter
LinkedIn
WhatsApp
YOU MAY ALSO LIKE